← SynDRA
BENZQUINAMIDE
SynDRA canonical compound SYN0023496 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Primary target(s) | DRD2 | PTGS2 |
| Mechanism of action | dopamine receptor agonist |
| Indication | nausea |
| Disease area | gastroenterology |
All known targets
- DRD2
- PTGS2
- ADRA2A
- ADRA2B
- ADRA2C
- DRD3
- DRD4
Mechanisms of action (all sources)
- DRD2 MODULATOR
- PTGS2 INHIBITOR
- DRD2 AGONIST
- dopamine receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR2A
- HTR2B
- ABL1
- NR1I2
- HTR1A
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MAPK1
- MC3R
- MC4R
- MLNR
- NPY1R
- NR3C1
- HRH2
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PPARG
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH3
- HRH1
- ADORA1
- CCKAR
- ADORA2A
- ADORA3
- ADRA1A
- ADRB1
- ADRB2
- AGTR1
- AURKA
- AVPR1A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- EMETE-CON
- benzquinamide hydrochloride
- emeticon
- promecon
- benzquinamide HCl
- Benzquinamida
- Benzchinamide
- Promecon
- NSC-108159
- NSC-169193
- NSC-64375
- P-2647
- Quantril
- Benzchinamid
- Benzchinamidum
- Benzochinamide
- Benzoquinamida
- Benzoquinamide
- Benzquinamid
- Benzquinamidum
- Emeticon
- Quantryl
- Benzoquinamida [INN-Spanish]
- Benzquinamide (USAN)
- Benzquinamidum [INN-Latin]
- Emete-con
- Benzquinamide [USAN:INN:BAN]
- benzquinamida
- P 2647
- DTXCID702657
- CHEBI:27662
- NSC64375
- RefChem:118822
- P2647;BZQ; Benzoquinamide
- HSDB 3295
- SCHEMBL49405
- GTPL7124
- orb1992737
Look up BENZQUINAMIDE in the interactive SynDRA portal →